SHW vs THAR · P/E 29, rev $12.46B vs $187.4M cap
Sherwin-Williams Co (SHW) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
THAR does not have a complete income-statement cache yet.
SHW currently screens at market cap $75.30B and trailing P/E 29.3. THAR currently screens at market cap $187.4M.
Not investment advice. Open the SHW and THAR stock pages for the full models.
Not investment advice.